1. Home
  2. NXL vs MPU Comparison

NXL vs MPU Comparison

Compare NXL & MPU Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NXL
  • MPU
  • Stock Information
  • Founded
  • NXL 2010
  • MPU 1989
  • Country
  • NXL United States
  • MPU Singapore
  • Employees
  • NXL N/A
  • MPU N/A
  • Industry
  • NXL Medical Specialities
  • MPU Transportation Services
  • Sector
  • NXL Health Care
  • MPU Consumer Discretionary
  • Exchange
  • NXL Nasdaq
  • MPU Nasdaq
  • Market Cap
  • NXL 31.1M
  • MPU 31.3M
  • IPO Year
  • NXL 2022
  • MPU 1998
  • Fundamental
  • Price
  • NXL $1.69
  • MPU $0.92
  • Analyst Decision
  • NXL Strong Buy
  • MPU
  • Analyst Count
  • NXL 1
  • MPU 0
  • Target Price
  • NXL $5.00
  • MPU N/A
  • AVG Volume (30 Days)
  • NXL 117.5K
  • MPU 63.9K
  • Earning Date
  • NXL 05-09-2025
  • MPU 05-07-2025
  • Dividend Yield
  • NXL N/A
  • MPU N/A
  • EPS Growth
  • NXL N/A
  • MPU N/A
  • EPS
  • NXL N/A
  • MPU N/A
  • Revenue
  • NXL $168,721.00
  • MPU $36,184,000.00
  • Revenue This Year
  • NXL $79.59
  • MPU N/A
  • Revenue Next Year
  • NXL $334.65
  • MPU N/A
  • P/E Ratio
  • NXL N/A
  • MPU N/A
  • Revenue Growth
  • NXL 52.35
  • MPU N/A
  • 52 Week Low
  • NXL $0.53
  • MPU $0.49
  • 52 Week High
  • NXL $4.49
  • MPU $2.69
  • Technical
  • Relative Strength Index (RSI)
  • NXL 37.97
  • MPU 65.57
  • Support Level
  • NXL $1.56
  • MPU $0.71
  • Resistance Level
  • NXL $2.31
  • MPU $0.95
  • Average True Range (ATR)
  • NXL 0.23
  • MPU 0.09
  • MACD
  • NXL 0.01
  • MPU 0.03
  • Stochastic Oscillator
  • NXL 24.27
  • MPU 90.63

About NXL Nexalin Technology Inc.

Nexalin Technology Inc designs and develops innovative neurostimulation products to uniquely and effectively help combat the ongoing global mental health epidemic. The company has developed an easy-to-administer medical device referred to as Generation 1 or Gen-1 that utilizes bioelectronic medical technology to treat anxiety and insomnia, without the need for drugs or psychotherapy. Its original Gen-1 devices are cranial electrotherapy stimulation (CES) devices that emit waveform at 4 milliamps during treatment and are presently classified by the U.S. Food and Drug Administration (FDA) as a Class II device.

About MPU Mega Matrix Corp.

Mega Matrix Inc formerly Mega Matrix Inc is a holding company. It operates through its two subsidiaries Mega Metaverse Corp (Mega) and JetFleet Management Corp (JMC). The Company has two business segments which are comprised of : ETH staking business and The leasing of regional aircraft to foreign and domestic regional airlines. The majority of the company's revenue is earned through Leasing business segment. The company operates in USA and Canada, Asia-Pacific, Europe, Middle East and Africa, and Latin America.

Share on Social Networks: